Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Peoniflorin
2. Peoniflorin Sulfonate
1. 23180-57-6
2. Peoniflorin
3. Paeonia Moutan
4. Paeony Root
5. Nsc 178886
6. 21aiq4ev64
7. ((2s,2ar,2a1s,3ar,4r,5ar)-4-hydroxy-2-methyl-2a-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)hexahydro-2h-1,5-dioxa-2,4-methanocyclobuta[cd]pentalen-2a1-yl)methyl Benzoate
8. Unii-21aiq4ev64
9. Ccris 6494
10. Nsc178886
11. Nsc-178886
12. .beta.-d-glucopyranoside, (1ar,2s,3ar,5r,5ar,5bs)-5b-((benzoyloxy)methyl)tetrahydro-5-hydroxy-2-methyl-2,5-methano-1h-3,4-dioxacyclobuta(cd)pentalen-1a(2h)-yl
13. .beta.-d-glucopyranoside, (1ar,2s,3ar,5r,5ar,5bs)-5b-[(benzoyloxy)methyl]tetrahydro-5-hydroxy-2-methyl-2,5-methano-1h-3,4-dioxacyclobuta[cd]pentalen-1a(2h)-yl
14. Einecs 245-476-2
15. Mfcd00869331
16. Peoniflorin [inci]
17. Paeoniflorin [usp-rs]
18. Schembl549033
19. Chebi:7889
20. Chembl4303209
21. Dtxsid2042648
22. Paeoniflorin, Analytical Standard
23. Paeoniflorin, >=98% (hplc)
24. Hms3884d17
25. Hy-n0293
26. Zinc8234328
27. S2410
28. Akos025311455
29. Ccg-269549
30. As-12193
31. Beta-d-glucopyranoside, (1as,2r,3ar,5r,5ar,5bs)-5b-((benzoyloxy)methyl)tetrahydro-5-hydroxy-2-methyl-2,5-methano-1h-3,4-dioxacyclobuta(cd)pentalen-1a(2h)-yl
32. C09959
33. Ab01566855_01
34. 180p576
35. Q-100296
36. Q7124104
37. ((2s,2ar,2a1s,3ar,4r,5ar)-4-hydroxy-2-methyl-2a-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)hexahydro-2h-1,5-dioxa-2,4-methanocyclobuta[cd]pentalen-2a1-yl)methylbenzoate
38. .beta.-d-glucopyranoside, 5b-((benzoyloxy)methyl)tetrahydro-5-hydroxy-2-methyl-2,5-methano-1h-3,4-dioxacyclobuta(cd)pentalen-1a(2h)-yl, (1ar-(1a.alpha.,2.beta.,3a.alpha.,5.alpha.,5a.alpha.,5b.alpha.))-
39. [(1r,2s,3r,5r,6r,8s)-6-hydroxy-8-methyl-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9,10-dioxatetracyclo[4.3.1.02,5.03,8]decan-2-yl]methyl Benzoate
40. [hydroxy-methyl-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-[?]yl]methyl Benzoate
41. 5b-((benzoyloxy)methyl)tetrahydro-5-hydroxy-2-methyl-2,5-methano-lh-3,4-dioxacyclobuta(cd)pentalen-1a(2h)-yl-beta-d-glucopyranoside
42. B-d-glucopyranoside,(1ar,2s,3ar,5r,5ar,5bs)-5b-[(benzoyloxy)methyl]tetrahydro-5-hydroxy-2-methyl-2,5-methano-1h-3,4-dioxacyclobuta[cd]pentalen-1a(2h)-yl
43. Beta-d-glucopyranoside, 5b-((benzoyloxy)methyl)tetrahydro-5-hydroxy-2-methyl-2,5-methano-1h-3,4-dioxacyclobuta(cd)pentalen-1a(2h)-yl, (1ar-(1a-alpha,2-beta,3a-alpha,5-alpha,5a-alpha,5b-alpha))-
44. Beta-d-glucopyranoside, 5b-((benzoyloxy)methyl)tetrahydro-5-hydroxy-2-methyl-2,5-methano-1h-3,4-dioxacyclobuta(cd)pentalen-1a(2h)-yl, (1ar-(1aalpha,2beta,3aalpha,5alpha,5aalpha,5balpha))-
| Molecular Weight | 480.5 g/mol |
|---|---|
| Molecular Formula | C23H28O11 |
| XLogP3 | -1 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 7 |
| Exact Mass | 480.16316171 g/mol |
| Monoisotopic Mass | 480.16316171 g/mol |
| Topological Polar Surface Area | 164 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 849 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 11 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
A Paeoniflorin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Paeoniflorin, including repackagers and relabelers. The FDA regulates Paeoniflorin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Paeoniflorin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Paeoniflorin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Paeoniflorin supplier is an individual or a company that provides Paeoniflorin active pharmaceutical ingredient (API) or Paeoniflorin finished formulations upon request. The Paeoniflorin suppliers may include Paeoniflorin API manufacturers, exporters, distributors and traders.
click here to find a list of Paeoniflorin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Paeoniflorin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Paeoniflorin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Paeoniflorin GMP manufacturer or Paeoniflorin GMP API supplier for your needs.
A Paeoniflorin CoA (Certificate of Analysis) is a formal document that attests to Paeoniflorin's compliance with Paeoniflorin specifications and serves as a tool for batch-level quality control.
Paeoniflorin CoA mostly includes findings from lab analyses of a specific batch. For each Paeoniflorin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Paeoniflorin may be tested according to a variety of international standards, such as European Pharmacopoeia (Paeoniflorin EP), Paeoniflorin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Paeoniflorin USP).
LOOKING FOR A SUPPLIER?
